CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

29.91 +1.03 (+3.57%)
Streaming Delayed Price Updated: 2:37 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 291,693
Open 29.40
Bid (Size) 29.86 (700)
Ask (Size) 29.91 (200)
Prev. Close 28.88
Today's Range 29.17 - 30.12
52wk Range 27.26 - 43.18
Shares Outstanding 45,882,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗
This clinical-stage biotech develops oncology therapies targeting unmet needs in cancer and immune-mediated conditions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
This healthcare firm develops advanced surgical solutions for peripheral nerve repair, serving hospitals and specialists worldwide. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-23.8%
-23.8%
1 Month
+1.0%
+1.0%
3 Month
-27.9%
-27.9%
6 Month
-19.7%
-19.7%
1 Year
-6.8%
-6.8%

More News

Read More
News headline image
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗
Via The Motley Fool
Topics Regulatory Compliance
AtriCure Inc (NASDAQ:ATRC) Stock Surges on Q4 2025 Earnings Beat and Profitability Milestone ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 29, 2025 ↗
Via Benzinga
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? ↗
Via The Motley Fool
Topics Derivatives Regulatory Compliance
News headline image
AtriCure to Participate in the Citizens Life Sciences Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure (ATRC) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
From Equity Insider
Via GlobeNewswire
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
From AtriCure, Inc.
Via Business Wire
News headline image
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure (ATRC) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
AtriCure Inc (NASDAQ:ATRC) Surpasses Q3 2025 Earnings Estimates and Raises Full-Year Outlook ↗
Via Chartmill
Topics Earnings
News headline image
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Third Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
From AtriCure, Inc.
Via Business Wire

Frequently Asked Questions

Is AtriCure, Inc. - Common Stock publicly traded?
Yes, AtriCure, Inc. - Common Stock is publicly traded.
What exchange does AtriCure, Inc. - Common Stock trade on?
AtriCure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtriCure, Inc. - Common Stock?
The ticker symbol for AtriCure, Inc. - Common Stock is ATRC on the Nasdaq Stock Market
What is the current price of AtriCure, Inc. - Common Stock?
The current price of AtriCure, Inc. - Common Stock is 29.91
When was AtriCure, Inc. - Common Stock last traded?
The last trade of AtriCure, Inc. - Common Stock was at 04/17/26 02:37 PM ET
What is the market capitalization of AtriCure, Inc. - Common Stock?
The market capitalization of AtriCure, Inc. - Common Stock is 1.37B
How many shares of AtriCure, Inc. - Common Stock are outstanding?
AtriCure, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article